ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OLK Olink Holding AB

23.97
0.04 (0.17%)
May 24 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Olink Holding AB OLK NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.04 0.17% 23.97 19:00:00
Open Price Low Price High Price Close Price Previous Close
23.93 23.52 24.01 23.97 23.93
more quote information »

Recent News

Date Time Source Heading
5/13/202405:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/13/202405:00GLOBEOlink reports first quarter 2024 financial results
4/19/202415:05GLOBEReport from the Annual General Meeting of Olink Holding AB..
4/02/202407:00GLOBEOlink® Insight Unveils Open-access Map of the Human..
3/25/202407:00GLOBEOlink reports fourth quarter and full year 2023 financial..
3/15/202407:00GLOBENotice to attend the Annual General Meeting of Olink Holding..
3/08/202407:00GLOBEOlink announces change of date for Annual General Meeting
3/06/202407:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
3/01/202415:45EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
2/20/202415:45EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
1/04/202415:45EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
12/22/202315:47EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
12/15/202315:45EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
11/15/202306:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/15/202306:00GLOBEOlink reports third quarter 2023 financial results
11/13/202316:12EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
11/05/202319:00GLOBENovogene Asia Pacific Middle East and Africa adopts Olink®..
10/31/202310:36EDGAR2Form SC 14D9 - Solicitation, recommendation statements
10/25/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/18/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/17/202317:40BWThermo Fisher Scientific prépare l'acquisition d'Olink,..
10/17/202317:39BWThermo Fisher Scientific übernimmt Olink, ein führendes..
10/17/202316:28EDGAR2Form SC14D9C - Written communication relating to third party..
10/17/202309:16DJNOlink Holding Shares Soar on Takeover by Thermo Fisher
10/17/202308:01DJNThermo Fisher to Buy Olink in $3.1 Billion Deal
10/17/202307:19BWThermo Fisher Scientific to Acquire Olink, a Leader in..
10/05/202315:25GLOBELandmark studies utilizing Olink® Explore technology signal..
9/19/202302:00GLOBEAnnouncing the Olink® Target 48 Mouse Cytokine Panel – the..
9/12/202310:00GLOBEEurofins Genomics adopts Olink® technology to advance..
8/29/202307:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/29/202307:00GLOBEOlink to participate in September investor events
8/17/202319:07EDGAR2Form 144 - Report of proposed sale of securities
8/09/202306:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/09/202306:00GLOBEOlink reports second quarter 2023 financial results
8/08/202307:00GLOBEBaylor College of Medicine Human Genome Sequencing Center..
7/13/202307:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/13/202307:00GLOBEOlink to report second quarter 2023 financial results on..
7/12/202308:00GLOBEAnnouncing Olink® Explore HT – A New Era in Proteomics
6/28/202307:00GLOBERevealing the secrets of the human proteome with Olink®..